Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
Public ClinicalTrials.gov record NCT04953962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Parallel Group, Phase 2 to Establish the Efficacy and Safety of Combinations of CBP501, Cisplatin, and Nivolumab for ≥3rd Line Treatment of Patients With Exocrine Pancreatic Cancer and WBC <10,000/mm3 at Screening
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Multicenter, randomized, open-label, parallel group phase 2 study to assess the efficacy and tolerance of four combinations of CBP501, cisplatin, and nivolumab administered once every 21 days to patients with stage IV exocrine pancreatic cancer and WBC \< 10,000/mm3 at screening.
Study identification
- NCT ID
- NCT04953962
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2021 (Actual)
- Primary completion
- Apr 14, 2023 (Actual)
- Completion
- Apr 14, 2023 (Actual)
- Last update posted
- Aug 15, 2023
2021 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, PC-HOPE | Tucson | Arizona | 85704 | — |
| Ochsner Clinic Foundation | Los Angeles | California | 70121 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Medical Oncology Hematology Consultants, PA | Newark | Delaware | 19713 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| University of Michigan hospital | Ann Arbor | Michigan | 48109 | — |
| Minnesota oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| James D Sanchez | Henderson | Nevada | 89052 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45245 | — |
| Texas Oncology-Austin Midtown | Austin | Texas | 78705 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75230 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology-McAllen South Second Street | McAllen | Texas | 78503 | — |
| Texas Oncology- McKinney | McKinney | Texas | 75071 | — |
| Texas Oncology-San Antonio Northeast | San Antonio | Texas | 78217 | — |
| Baylor Scott & White Medical Center | Temple | Texas | 76508 | — |
| Texas Oncology-Northeast Texas | Tyler | Texas | 75702 | — |
| Virginia Cancer Specialists, PC | Arrington | Virginia | 22205 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04953962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04953962 live on ClinicalTrials.gov.